This Supplement to AMR Control is a collaboration between Global Health Dynamics and the Union for International Cancer Control (UICC) to provide the cancer community at all levels with up-to-date information and insights on the threat of antimicrobial resistance. More than 50 authors from both the AMR and cancer specialities, and the UICC-led Task Force on AMR and Cancer Care, have come together to produce this. The full Supplement can be accessed below in a variety of formats to suit the reader.
Highlights from AMR Control Supplement: The Challenge for the Cancer Community
AMR Control 2019–2020
The AMR Clinical Reference Center (AMRCRC) was established in 2017 to implement the National Action Plan on Antimicrobial Resistance (AMR) and consists of three divisions that together lead the fight against AMR in Japan.
Phage therapy: A promising weapon in the global superbug crisis Dr Steffanie Strathdee, Associate Dean of Global Health Sciences, Harold Simon Professor of Medicine and Co-Director, Center for Innovative Phage Applications
Global governance to tackle antimicrobial resistance: The way forward Dr Haileyesus Getahun, Director, UN Interagency Coordination on Antimicrobial Resistance, Division of Antimicrobial Resistance, World Health Organisation and
The Global AMR R&D Hub – Enhancing the international coordination of antimicrobial resistance research and development Dr Jennie Hood, Scientific Programme Officer
Leading articles from AMR Control 2018
Left unchecked, antimicrobial resistance (AMR) will roll back a century of medical progress, damage the environment, interrupt food production, cause more people to fall into extreme poverty and imperil global
In 2015, the Swiss Federal Council adopted a national strategy to ensure the long-term efficacy of antibiotics, while preserving human and animal health. Developed through a consultation process…
There is an urgent need to consider and develop long-term, sustainable solutions that take into account the complex drivers of AMR cross-cutting the human, animal and environmental sectors.
CARB-X stands for Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator.
Highlights from AMR Control – Édition Française 2018
Le Plan d’action mondial pour combattre la résistance aux antimicrobiens (GAPAMR), adopté par l’Assemblée mondiale de la Santé en 2015…
La Résistance aux Antibiotiques au Liban Professeure Pascale SalamehProfesseur titulaire d’épidémiologie, facultés de pharmacie et de médecine, Université Libanaise, Hadath, Liban ; Dr Hala Sacre Directrice du Centre d’information sur le médicament à l’Ordre des...
En partenariat avec le service des laboratoires du Ministère de la Santé Publique, la Fondation Mérieux a lancé en 2016 un projet pilote de mise en place d’un laboratoire de bactériologie…
Le réseau algérien sur la résistance aux antimicrobiens a détecté des taux élevés de pharmacorésistance montrant, par exemple, que près d’une entérobactérie sur trois était productrice d’une…
The AMR Control series
Global Health Dynamics
Global Health Dynamics
20 Quayside,Woodbridge, Suffolk IP12 1BH, UK
t: +44 1394 446023
m: +44 7960 727938
tprobart@globalhealthdynamics.co.uk
www.globalhealthdynamics.co.uk
